81
Participants
Start Date
July 31, 2012
Primary Completion Date
December 31, 2013
Study Completion Date
December 31, 2013
Clopidogrel
Patient will be randomized to this intervention will receive in the first time the double dose of clopidogrel and after 15 days and 30 days we will control the responsivness of the study drug.
Prasugrel
Patient will be randomized to this intervention will receive in the first time prasugrel and after 15 days and 30 days we will control the responsivness of the study drug.
Ticagrelor
Patient will be randomized to this intervention will receive in the first time Ticagrelor and after 14 days and 28 days we will change their therapy with the high clopidogrel dose or Prasugrel (dual crossover).
Dept.of Cardiovascular Sciences,Policlinico Umberto I, Rome
University of Roma La Sapienza
OTHER